Cahilap, Nelia M.
HRN: 23-28-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2023
CEFTRIAXONE 1G (VIAL)
07/03/2023
07/09/2023
IVT
2g
Q24
T/C Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes